This programme aims to generate new knowledge about interventions by funding research that will contribute to the improvement of health in low and middle income countries, particularly addressing questions of major importance to mortality and morbidity.
Launched in 2010, the Joint Global Health Trials (JGHT) scheme provides funding for research to generate new knowledge about interventions that will contribute to the improvement of health in low and middle income countries.
The partner agencies believe that in order to have maximum impact on health we need to work together to provide evidence of the best and most appropriate interventions.
The purpose of this scheme is to fund rigorous research to produce implementable evidence addressing questions of major importance to mortality and morbidity in low and middle income countries. The scheme primarily funds randomised clinical trials but innovative trial methodologies and adaptive designs are also welcome. The scheme focuses on late-stage (equivalent to phase 3 and 4) clinical and health intervention trials that evaluate efficacy and effectiveness but we may also consider phase 2b stage trials if they are of major relevance to the objectives of the funding opportunity.
The scheme funded proposals for any major health related problem affecting low and middle income countries, particularly those that affect the most vulnerable populations. Although the breadth of the scheme is deliberately wide, we particularly welcomed proposals for research into chronic non-communicable diseases, including mental health, reproductive, maternal and newborn health.